Evidence map›Paper›PMID 29395072›Full record

ArticleAmerican journal of human genetics2018

Truncated SALL1 Impedes Primary Cilia Function in Townes-Brocks Syndrome.

Laura Bozal-Basterra, Itziar Martín-Ruíz, Lucia Pirone, Yinwen Liang, Jón Otti Sigurðsson, Maria Gonzalez-Santamarta, Immacolata Giordano, Estibaliz Gabicagogeascoa, Angela de Luca, Jose A Rodríguez and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Branchio-oto-renal syndrome: a narrative review.Childhood kidney diseases · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Actin cytoskeletal regulation of ciliogenesis in development and disease.Developmental dynamics : an official publication of the American Association of Anatomists · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Ciliopathies in pediatric endocrinology.Annals of pediatric endocrinology & metabolism · 2023
    Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Clinical and genetic heterogeneity of primary ciliopathies (Review).International journal of molecular medicine · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 8 institutions in 4 countries.

Laura Bozal-BasterraCIC bioGUNE, Bizkaia Technology Park, Building 801-A, 48160 Derio, Bizkaia, Spain.
Itziar Martín-RuízCIC bioGUNE, Bizkaia Technology Park, Building 801-A, 48160 Derio, Bizkaia, Spain.
Lucia PironeCIC bioGUNE, Bizkaia Technology Park, Building 801-A, 48160 Derio, Bizkaia, Spain.
Yinwen LiangMemorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.
Jón Otti SigurðssonNovo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3b, 2200 Copenhagen, Denmark.
Maria Gonzalez-SantamartaCIC bioGUNE, Bizkaia Technology Park, Building 801-A, 48160 Derio, Bizkaia, Spain.
Immacolata GiordanoCIC bioGUNE, Bizkaia Technology Park, Building 801-A, 48160 Derio, Bizkaia, Spain.
Estibaliz GabicagogeascoaCIC bioGUNE, Bizkaia Technology Park, Building 801-A, 48160 Derio, Bizkaia, Spain.
Angela de LucaCIC bioGUNE, Bizkaia Technology Park, Building 801-A, 48160 Derio, Bizkaia, Spain.
Jose A RodríguezDepartment of Genetics, Physical Anthropology, and Animal Physiology, University of the Basque Country (UPV/EHU), Leioa, Spain.
Andrew O M WilkieWeatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Jürgen KohlhaseSYNLAB Center for Human Genetics Freiburg, Heinrich-von-Stephan-Straße 5, 79100 Freiburg, Germany.
Deborah EastwoodGreat Ormond Street Hospital, Great Ormond Street, London WC1N 3JH, UK.
Christopher YaleIpswich Hospital NHS Trust, Heath Road, Ipswich IP4 5PD, Suffolk, UK.
Jesper V OlsenNovo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3b, 2200 Copenhagen, Denmark.
Michael RauchmanSaint Louis University School of Medicine, 1100 South Grand Boulevard, St. Louis, MO 63104, USA; VA St. Louis Health Care System, St. Louis, MO 63106, USA.
Kathryn V AndersonMemorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.
James D SutherlandCIC bioGUNE, Bizkaia Technology Park, Building 801-A, 48160 Derio, Bizkaia, Spain. Electronic address: jsutherland@cicbiogune.es.
Rosa BarrioCIC bioGUNE, Bizkaia Technology Park, Building 801-A, 48160 Derio, Bizkaia, Spain. Electronic address: rbarrio@cicbiogune.es.
CIC bioGUNE · ESMemorial Sloan Kettering Cancer Center · USNovo Nordisk Foundation · DKGreat Ormond Street Hospital · GBIpswich Hospital · GBUniversity of Oxford · GBUniversity of the Basque Country · ESVA St. Louis Health Care System · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Regulation of Nephron Progenitor Cell Self-Renewal and DifferentiationR01DK098563 · NIDDK · WASHINGTON UNIVERSITY · PI RAUCHMAN, MICHAEL I · 2014 to 2017
$1.3M
NCI NIH HHS P30 CA008748NIDDK NIH HHS R01 DK098563Wellcome Trust 102731/Z/13/Z
6 · The paper itself

Abstract

Townes-Brocks syndrome (TBS) is characterized by a spectrum of malformations in the digits, ears, and kidneys. These anomalies overlap those seen in a growing number of ciliopathies, which are genetic syndromes linked to defects in the formation or function of the primary cilia. TBS is caused by mutations in the gene encoding the transcriptional repressor SALL1 and is associated with the presence of a truncated protein that localizes to the cytoplasm. Here, we provide evidence that SALL1 mutations might cause TBS by means beyond its transcriptional capacity. By using proximity proteomics, we show that truncated SALL1 interacts with factors related to cilia function, including the negative regulators of ciliogenesis CCP110 and CEP97. This most likely contributes to more frequent cilia formation in TBS-derived fibroblasts, as well as in a CRISPR/Cas9-generated model cell line and in TBS-modeled mouse embryonic fibroblasts, than in wild-type controls. Furthermore, TBS-like cells show changes in cilia length and disassembly rates in combination with aberrant SHH signaling transduction. These findings support the hypothesis that aberrations in primary cilia and SHH signaling are contributing factors in TBS phenotypes, representing a paradigm shift in understanding TBS etiology. These results open possibilities for the treatment of TBS.

Indexed as

Abnormalities, MultipleAnimalsAnus, ImperforateCiliaCytoplasmEmbryo, MammalianFibroblastsHearing Loss, SensorineuralHedgehog ProteinsHEK293 CellsHumansInfant, NewbornMiceMutationPhenotypeProtein BindingHedgehog ProteinsSALL1 protein, humanSHH protein, humanTranscription FactorsBioIDprimary ciliarare diseaseSALL1spaltTownes-Brocks syndrome

Identifiers

PMID29395072
PMCPMC5985538
OpenAlexW2787832025

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.